Namely, HO-1 derived from the vascular endothelium may be involved in the suppression of GVL effects and GVHD development, whereas HO-1 derived from donor blood cells may be mainly responsible for its anti-inflammatory and cytoprotective effects, leading to the prevention of organ damage. The gene discussed is HMOX1; the disease is graft versus host disease.